Year's hottest headed for trouble?
Share

Year's hottest headed for trouble?

Sam Isaly, OrbiMed Advisors managing partner, says valuations are more than they used to be but adds, they're not crazy, they're sensible. He shares his view of the biotech sector.
04:32
Wed, Apr 1 201512:32 PM EDT